JT

Juliet Tammenoms Bakker

Founder of Longitude Capital

Greenwich, Connecticut

Overview 

Juliet Tammenoms Bakker is the Co-Founder and Managing Director at Longitude Capital in Greenwich, Connecticut, where she has overseen investments in a variety of sectors including Medical Devices and BioTech. With a background in Life Sciences Venture Capital, she has served on the boards of several successful companies like Ceribell and Endogenex, demonstrating a strong track record of strategic leadership and investment acumen.

Work Experience 

  • Co-Founder, Managing Director

    2007 - Current

Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.

  • Board Member

    2021

Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.

Raised $171,000,000.00 from Ally Bridge Group, Red Tree Venture Capital, The Rise Fund, Longitude Capital, RA Capital Management and Redmile Group.

  • Board Member

    2023

  • Board Member

    2018

Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.

Raised $112,996,355.00 from Intuitive Ventures, Orlando Health Ventures, Mayo Clinic, Lumira Ventures, Longitude Capital, Hatteras Venture Partners and Sante Ventures.

  • Board Member

    2015

Nalu Medical is a medical technology company that develops innovative solutions for patients with chronic neuropathic pain.

Raised $200,915,367.00 from Pura Vida Investments, Aperture Venture Partners, Advent Life Sciences, Longitude Capital, B Capital, Decheng Capital, Endeavour Vision, Novo Holdings, Gilde Healthcare and MVM Life Science Partners.

  • Board Member

    2015

RxSight is a medical device company that offers an intraocular lens and cataract surgery solutions.

Raised $350,975,917.00 from Armentum Partners, Oxford Finance LLC, H.I.G. BioHealth Partners, Balance Point Capital Partners and Longitude Capital.

  • Board Member

    2020 - 2021

Eargo specializes in the design and development of hearing aids.

Raised $371,476,928.00 from Patient Square Capital.

  • Director

    1997 - 2015

    Aquesys, Ablation Frontiers, Aptus Endosystems, Broncus Technologies, Cryovascular Systems, Disc Dynamics, Embolic Protection, Enteric Medical, Facet Solutions, eyeonics, Genyx Medical, Insulet (NASDAQ:PODD), PixelOptics, Precision Dermatology, Sadra Medical and Sanarus Medical.

  • Managing Director, Co-head of Life Sciences Venture Capital Practice

    1997 - 2006

Articles About Juliet

Relevant Websites